iShares US Healthcare E.T.F. (IYH) Buy, Sell…

Home

Daily Stock Opinions and Ratings

iShares US Healthcare E.T.F. (IYH)

66.99

-0.81 (1.19%)

as of Jul 20, 2026, 8:00:00 pm Market Open.

21 watching

Investor Insights

Jul 20, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

The iShares US Healthcare E.T.F. (IYH-N) is currently benefiting from improvements in Medical Loss Ratio (MLR) expectations for managed-care companies, which indicates a positive trend in managing healthcare costs. Experts are optimistic about potential clarity surrounding Medicare Advantage, which may contribute to more stable and predictable revenue streams. This enhances investor confidence in the healthcare sector, suggesting a favorable outlook for managed-care firms within the ETF. Overall, the sentiment reflects a supportive environment for growth in healthcare investments as reforms and competitive dynamics evolve. These improvements could lead to enhanced profitability for companies within the fund, further solidifying its position in the market.

Consensus

Positive

Valuation

Fair Value

Similar

Vaccine, PFE

COMMENT

Healthcare tends to be a little less correlated to the equity market, so it is an ideal place to be. We are approaching the seasonal strength for biotech at the end of June. The chart on this is showing higher lows and higher highs. A similar one, but hedged to the Cdn$, would be BMO Equal Weight US Healthcare (ZUH-T). (See Top Picks.)

BUY

Owns all the large US healthcare names. Continues to move along at a very nice clip.

BUY

This has big holdings in things like Johnson & Johnson (JNJ-N), Pfizer (PFE-N), Merck (MRK-N), etc. Has done very well year to date.

BUY ON WEAKNESS

Likes this area. Going forward, it will be a defensive space. Broke out past its previous resistance point. If you own, Hold. You could add to that on pullbacks.

BUY

Have liked the sector for quite awhile. Has outperformed the S & P 500 since the beginning of the year. Very heavily weighted to large pharma. Short term there's a little bit of a risk, but long term, it's a place you want to have exposure to.

Showing 16 to 20 of 20 entries

Most Recent Experts

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

David Driscoll

Liberty International Investment Management Inc

Malcolm Ethridge, Mgn. partner, Capital Area Planning Group

Capital Area Planning Group

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

iShares US Healthcare E.T.F. (IYH)